http://www.japancorp.netJCN Newswire - Recent Headline Newsen-usCopyright 2012, JCN Newswire10http://www.japancorp.net/images/jcnxml.jpghttp://www.japancorp.net8831JCN Newswirehttp://www.japancorp.net/press_release/24817/singapore_scientists_lead_in_3d_mapping_of_human_genome_to_help_understand_human_diseaseshttp://www.japancorp.net/press_release/24817/singapore_scientists_lead_in_3d_mapping_of_human_genome_to_help_understand_human_diseasesThis discovery is crucial in understanding how human genes work together, and will re-write textbooks on how transcription regulation and coordination takes place in human cells.Wed,1 Feb 2012 19:00:0 +0000http://www.japancorp.net/press_release/24779/cambridge_team_first_to_grow_smooth_muscle_cells_from_patient_skin_cellshttp://www.japancorp.net/press_release/24779/cambridge_team_first_to_grow_smooth_muscle_cells_from_patient_skin_cellsA Cambridge University research team has for the first time, discovered a method of generating different types of vascular smooth muscle cells (SMCs) - the cells which make up the walls of blood vessels - using cells from patients' skin.Thu,26 Jan 2012 16:10:26 +0000http://www.japancorp.net/press_release/24762/astar_ge_global_research_join_forces_to_develop_integrated_advanced_medical_imaging_technologieshttp://www.japancorp.net/press_release/24762/astar_ge_global_research_join_forces_to_develop_integrated_advanced_medical_imaging_technologiesThis agreement will focus on advancing current medical imaging technologies and diagnostics to enable more accurate, earlier and faster clinical diagnoses of cancer and other diseases.Sat,21 Jan 2012 13:00:14 +0000http://www.japancorp.net/press_release/24752/eisai_and_eidia_announce_launch_of_life_check_a_selfmonitoring_blood_glucose_meter_that_is_easy_for_elderly_diabetes_patients_to_usehttp://www.japancorp.net/press_release/24752/eisai_and_eidia_announce_launch_of_life_check_a_selfmonitoring_blood_glucose_meter_that_is_easy_for_elderly_diabetes_patients_to_useEisai's diagnostics subsidiary EIDIA will launch LIFE CHECK, a self-monitoring blood glucose meter manufactured by Gunze Limited, on January 27, 2012.Thu,19 Jan 2012 14:38:42 +0000http://www.japancorp.net/press_release/24750/eisai_receives_approval_to_market_insomnia_treatment_lunesta_in_japanhttp://www.japancorp.net/press_release/24750/eisai_receives_approval_to_market_insomnia_treatment_lunesta_in_japanEisai has received approval from Japan's Ministry of Health, Labour and Welfare to market Lunesta, a product the company has been developing in Japan, as a treatment for insomnia.Wed,18 Jan 2012 17:22:40 +0000http://www.japancorp.net/press_release/24746/next_generation_plastics_promises_fresher_foods_and_medicines_and_better_protection_for_surfaceshttp://www.japancorp.net/press_release/24746/next_generation_plastics_promises_fresher_foods_and_medicines_and_better_protection_for_surfacesFood that stays fresher for longer and varnishes that keep furniture looking new is the goal of new plastic technologies to be developed by a consortium set up by A*STAR's IMRE and its industry partners.Wed,18 Jan 2012 14:00:22 +0000http://www.japancorp.net/press_release/24736/nobelpharma_and_eisai_announce_japan_launch_of_anticonvulsant_agent_fostoin_750_mg_for_injectionhttp://www.japancorp.net/press_release/24736/nobelpharma_and_eisai_announce_japan_launch_of_anticonvulsant_agent_fostoin_750_mg_for_injectionNobelpharma and Eisai will launch the anticonvulsant agent Fostoin 750 mg for Injection (fostoin) on January 17.Mon,16 Jan 2012 15:18:59 +0000http://www.japancorp.net/press_release/24689/arena_submits_response_to_fda_complete_response_letter_for_lorcaserinhttp://www.japancorp.net/press_release/24689/arena_submits_response_to_fda_complete_response_letter_for_lorcaserinEisai announced that Arena Pharmaceuticals has submitted its response to the Complete Response Letter (CRL) issued by the FDA following review of the lorcaserin New Drug Application.Thu,5 Jan 2012 18:18:13 +0000http://www.japancorp.net/press_release/24660/eisai_resubmits_ampa_receptor_antagonist_perampanel_e2007_nda_to_us_fdahttp://www.japancorp.net/press_release/24660/eisai_resubmits_ampa_receptor_antagonist_perampanel_e2007_nda_to_us_fdaEisai resubmitted the New Drug Application (NDA) for the investigational AMPA receptor antagonist perampanel for partial-onset seizures associated with epilepsy to the U.S. Food and Drug Administration.Mon,26 Dec 2011 12:08:32 +0000http://www.japancorp.net/press_release/24642/eisai_submits_application_for_partial_change_to_label_of_egg_white_lysozyme_preparation_neuzymhttp://www.japancorp.net/press_release/24642/eisai_submits_application_for_partial_change_to_label_of_egg_white_lysozyme_preparation_neuzymEisai's pharmaceutical manufacturing and marketing subsidiary Sannova Co. Ltd submitted an application for partial change to the approved label for egg white lysozyme preparation Neuzym to Japan's Ministry of Health, Labour and Welfare.Wed,21 Dec 2011 16:26:36 +0000